Advancing medicines
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies opportunities others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.
Our success is proven
2
Billion PharmFilm doses consumed by patients
200+
Worldwide patents
4
Continents where our products are sold
Latest news
-
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy’s Laboratories from Launching its Generic Suboxone Product
WARREN, N.J., July 16, 2018 /PRNewswire/ — Aquestive Therapeutics (“Aquestive”) announces today that the U.S. District Court for the District of New Jersey has granted Aquestive ...
-
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
Warren, NJ, May 18, 2018 – Aquestive Therapeutics today announced that a settlement agreement has been reached resolving patent litigation related to SUBOXONE® (buprenorphine and naloxone) Subling...
